Verisk Maplecroft Named Best Specialist ESG Ratings 28-02-2023, 02:37

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab) 22-10-2024, 18:00

Lawrie Insurance Group Announces New Chief Operating 2-02-2023, 01:56